nodes	percent_of_prediction	percent_of_DWPC	metapath
Amikacin—High frequency deafness—Cisplatin—urinary bladder cancer	0.18	0.18	CcSEcCtD
Amikacin—Ototoxicity—Thiotepa—urinary bladder cancer	0.0548	0.0548	CcSEcCtD
Amikacin—Ototoxicity—Cisplatin—urinary bladder cancer	0.043	0.043	CcSEcCtD
Amikacin—Nephropathy toxic—Mitomycin—urinary bladder cancer	0.0381	0.0381	CcSEcCtD
Amikacin—Nephrotoxicity—Cisplatin—urinary bladder cancer	0.0271	0.0271	CcSEcCtD
Amikacin—Neurotoxicity—Gemcitabine—urinary bladder cancer	0.0239	0.0239	CcSEcCtD
Amikacin—Neurotoxicity—Cisplatin—urinary bladder cancer	0.0222	0.0222	CcSEcCtD
Amikacin—Neurotoxicity—Etoposide—urinary bladder cancer	0.0204	0.0204	CcSEcCtD
Amikacin—Nephropathy toxic—Gemcitabine—urinary bladder cancer	0.0161	0.0161	CcSEcCtD
Amikacin—Blindness—Cisplatin—urinary bladder cancer	0.0156	0.0156	CcSEcCtD
Amikacin—Nephropathy toxic—Cisplatin—urinary bladder cancer	0.015	0.015	CcSEcCtD
Amikacin—Hypomagnesaemia—Gemcitabine—urinary bladder cancer	0.0146	0.0146	CcSEcCtD
Amikacin—Nephropathy toxic—Etoposide—urinary bladder cancer	0.0138	0.0138	CcSEcCtD
Amikacin—Anaemia—Valrubicin—urinary bladder cancer	0.0128	0.0128	CcSEcCtD
Amikacin—Neurotoxicity—Methotrexate—urinary bladder cancer	0.0122	0.0122	CcSEcCtD
Amikacin—Oliguria—Thiotepa—urinary bladder cancer	0.0119	0.0119	CcSEcCtD
Amikacin—Hearing impaired—Thiotepa—urinary bladder cancer	0.0116	0.0116	CcSEcCtD
Amikacin—Neurotoxicity—Epirubicin—urinary bladder cancer	0.0114	0.0114	CcSEcCtD
Amikacin—Neurotoxicity—Doxorubicin—urinary bladder cancer	0.0106	0.0106	CcSEcCtD
Amikacin—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.0103	0.0103	CcSEcCtD
Amikacin—Hearing impaired—Gemcitabine—urinary bladder cancer	0.00972	0.00972	CcSEcCtD
Amikacin—Apnoea—Etoposide—urinary bladder cancer	0.00932	0.00932	CcSEcCtD
Amikacin—Hearing impaired—Cisplatin—urinary bladder cancer	0.00906	0.00906	CcSEcCtD
Amikacin—Body temperature increased—Valrubicin—urinary bladder cancer	0.00895	0.00895	CcSEcCtD
Amikacin—Deafness—Thiotepa—urinary bladder cancer	0.00892	0.00892	CcSEcCtD
Amikacin—Azotaemia—Methotrexate—urinary bladder cancer	0.00888	0.00888	CcSEcCtD
Amikacin—Anaemia—Mitomycin—urinary bladder cancer	0.00883	0.00883	CcSEcCtD
Amikacin—Body temperature increased—Carboplatin—urinary bladder cancer	0.00829	0.00829	CcSEcCtD
Amikacin—Blindness—Epirubicin—urinary bladder cancer	0.008	0.008	CcSEcCtD
Amikacin—Deafness—Gemcitabine—urinary bladder cancer	0.00751	0.00751	CcSEcCtD
Amikacin—Blindness—Doxorubicin—urinary bladder cancer	0.0074	0.0074	CcSEcCtD
Amikacin—Vomiting—Valrubicin—urinary bladder cancer	0.0072	0.0072	CcSEcCtD
Amikacin—Rash—Valrubicin—urinary bladder cancer	0.00714	0.00714	CcSEcCtD
Amikacin—Dermatitis—Valrubicin—urinary bladder cancer	0.00713	0.00713	CcSEcCtD
Amikacin—Headache—Valrubicin—urinary bladder cancer	0.00709	0.00709	CcSEcCtD
Amikacin—Deafness—Cisplatin—urinary bladder cancer	0.007	0.007	CcSEcCtD
Amikacin—Hypomagnesaemia—Epirubicin—urinary bladder cancer	0.00697	0.00697	CcSEcCtD
Amikacin—Paralysis—Methotrexate—urinary bladder cancer	0.00681	0.00681	CcSEcCtD
Amikacin—Renal failure acute—Cisplatin—urinary bladder cancer	0.00678	0.00678	CcSEcCtD
Amikacin—Nausea—Valrubicin—urinary bladder cancer	0.00673	0.00673	CcSEcCtD
Amikacin—Hypomagnesaemia—Doxorubicin—urinary bladder cancer	0.00645	0.00645	CcSEcCtD
Amikacin—Paralysis—Epirubicin—urinary bladder cancer	0.00637	0.00637	CcSEcCtD
Amikacin—Body temperature increased—Mitomycin—urinary bladder cancer	0.00617	0.00617	CcSEcCtD
Amikacin—Albuminuria—Epirubicin—urinary bladder cancer	0.00593	0.00593	CcSEcCtD
Amikacin—Paralysis—Doxorubicin—urinary bladder cancer	0.0059	0.0059	CcSEcCtD
Amikacin—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00565	0.00565	CcSEcCtD
Amikacin—Apnoea—Methotrexate—urinary bladder cancer	0.00558	0.00558	CcSEcCtD
Amikacin—Albuminuria—Doxorubicin—urinary bladder cancer	0.00549	0.00549	CcSEcCtD
Amikacin—Oliguria—Methotrexate—urinary bladder cancer	0.00513	0.00513	CcSEcCtD
Amikacin—Vomiting—Mitomycin—urinary bladder cancer	0.00496	0.00496	CcSEcCtD
Amikacin—Rash—Mitomycin—urinary bladder cancer	0.00492	0.00492	CcSEcCtD
Amikacin—Dermatitis—Mitomycin—urinary bladder cancer	0.00491	0.00491	CcSEcCtD
Amikacin—Headache—Mitomycin—urinary bladder cancer	0.00489	0.00489	CcSEcCtD
Amikacin—Oliguria—Epirubicin—urinary bladder cancer	0.0048	0.0048	CcSEcCtD
Amikacin—Nausea—Mitomycin—urinary bladder cancer	0.00463	0.00463	CcSEcCtD
Amikacin—Oliguria—Doxorubicin—urinary bladder cancer	0.00444	0.00444	CcSEcCtD
Amikacin—Anaemia—Thiotepa—urinary bladder cancer	0.00444	0.00444	CcSEcCtD
Amikacin—Arthralgia—Thiotepa—urinary bladder cancer	0.00409	0.00409	CcSEcCtD
Amikacin—Anaemia—Gemcitabine—urinary bladder cancer	0.00374	0.00374	CcSEcCtD
Amikacin—Renal failure acute—Methotrexate—urinary bladder cancer	0.00372	0.00372	CcSEcCtD
Amikacin—Anaemia—Fluorouracil—urinary bladder cancer	0.00367	0.00367	CcSEcCtD
Amikacin—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00357	0.00357	CcSEcCtD
Amikacin—Tremor—Cisplatin—urinary bladder cancer	0.00353	0.00353	CcSEcCtD
Amikacin—Paraesthesia—Thiotepa—urinary bladder cancer	0.00352	0.00352	CcSEcCtD
Amikacin—Anaemia—Cisplatin—urinary bladder cancer	0.00348	0.00348	CcSEcCtD
Amikacin—Renal failure acute—Epirubicin—urinary bladder cancer	0.00348	0.00348	CcSEcCtD
Amikacin—Arthralgia—Gemcitabine—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Amikacin—Renal failure acute—Doxorubicin—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Amikacin—Anaemia—Etoposide—urinary bladder cancer	0.00319	0.00319	CcSEcCtD
Amikacin—Body temperature increased—Thiotepa—urinary bladder cancer	0.0031	0.0031	CcSEcCtD
Amikacin—Hypotension—Gemcitabine—urinary bladder cancer	0.00308	0.00308	CcSEcCtD
Amikacin—Hypotension—Fluorouracil—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Amikacin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Amikacin—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00296	0.00296	CcSEcCtD
Amikacin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00296	0.00296	CcSEcCtD
Amikacin—Eosinophilia—Methotrexate—urinary bladder cancer	0.00294	0.00294	CcSEcCtD
Amikacin—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Amikacin—Hypotension—Cisplatin—urinary bladder cancer	0.00287	0.00287	CcSEcCtD
Amikacin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Amikacin—Paraesthesia—Cisplatin—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Amikacin—Eosinophilia—Epirubicin—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Amikacin—Hypotension—Etoposide—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Amikacin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Amikacin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Amikacin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Amikacin—Paraesthesia—Etoposide—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Amikacin—Vomiting—Thiotepa—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Amikacin—Rash—Thiotepa—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Amikacin—Dermatitis—Thiotepa—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Amikacin—Headache—Thiotepa—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Amikacin—Body temperature increased—Cisplatin—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Amikacin—Nausea—Thiotepa—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Amikacin—Body temperature increased—Etoposide—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Amikacin—Vomiting—Gemcitabine—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Amikacin—Rash—Gemcitabine—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Amikacin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Amikacin—Headache—Gemcitabine—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Amikacin—Vomiting—Fluorouracil—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Amikacin—Rash—Fluorouracil—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Amikacin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Amikacin—Headache—Fluorouracil—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Amikacin—Nausea—Gemcitabine—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Amikacin—Vomiting—Cisplatin—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Amikacin—Rash—Cisplatin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Amikacin—Dermatitis—Cisplatin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Amikacin—Nausea—Fluorouracil—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Amikacin—Anaemia—Methotrexate—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Amikacin—Nausea—Cisplatin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Amikacin—Vomiting—Etoposide—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Amikacin—Anaemia—Epirubicin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Amikacin—Rash—Etoposide—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Amikacin—Dermatitis—Etoposide—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Amikacin—Headache—Etoposide—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Amikacin—Arthralgia—Methotrexate—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Amikacin—Nausea—Etoposide—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Amikacin—Anaemia—Doxorubicin—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Amikacin—Arthralgia—Epirubicin—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Amikacin—Hypotension—Methotrexate—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Amikacin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Amikacin—Arthralgia—Doxorubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Amikacin—Paraesthesia—Methotrexate—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Amikacin—Hypotension—Epirubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Amikacin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Amikacin—Paraesthesia—Epirubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Amikacin—Hypotension—Doxorubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Amikacin—Body temperature increased—Methotrexate—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Amikacin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Amikacin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Amikacin—Body temperature increased—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Amikacin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Amikacin—Vomiting—Methotrexate—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Amikacin—Rash—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Amikacin—Dermatitis—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Amikacin—Headache—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Amikacin—Vomiting—Epirubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Amikacin—Nausea—Methotrexate—urinary bladder cancer	0.001	0.001	CcSEcCtD
Amikacin—Rash—Epirubicin—urinary bladder cancer	0.000996	0.000996	CcSEcCtD
Amikacin—Dermatitis—Epirubicin—urinary bladder cancer	0.000995	0.000995	CcSEcCtD
Amikacin—Headache—Epirubicin—urinary bladder cancer	0.000989	0.000989	CcSEcCtD
Amikacin—Nausea—Epirubicin—urinary bladder cancer	0.000938	0.000938	CcSEcCtD
Amikacin—Vomiting—Doxorubicin—urinary bladder cancer	0.000929	0.000929	CcSEcCtD
Amikacin—Rash—Doxorubicin—urinary bladder cancer	0.000921	0.000921	CcSEcCtD
Amikacin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000921	0.000921	CcSEcCtD
Amikacin—Headache—Doxorubicin—urinary bladder cancer	0.000916	0.000916	CcSEcCtD
Amikacin—Nausea—Doxorubicin—urinary bladder cancer	0.000868	0.000868	CcSEcCtD
